Literature DB >> 29454968

Ess2 bridges transcriptional regulators and spliceosomal complexes via distinct interacting domains.

Ichiro Takada1, Megumi Tsuchiya2, Kaori Yanaka3, Shinya Hidano4, Sayuri Takahashi5, Takashi Kobayashi4, Hidesato Ogawa2, Sinichi Nakagawa3, Makoto Makishima6.   

Abstract

Transcription and pre-mRNA splicing are complex, coupled processes that involve transcriptional co-regulators. Ess2 (also termed Dgcr14) is a nuclear protein that enhances the transcriptional activity of retinoic acid receptor-related orphan receptor gamma/gamma-t (Rorγ/γt). Ess2 is also a component of the spliceosomal C complex (containing U2, U5 and U6 snRNAs). However, the domains in Ess2 that function in splicing and transcription have not been identified. To elucidate the roles of Ess2 in splicing and transcription, we performed RNA immunoprecipitation (RIP) assays to detect Ess2-interacting snRNAs. We found that Ess2 associated with U6 snRNA as well as U1 and U4 snRNAs. Experiments using Ess2 deletion mutants showed that a C-terminus deletion mutant of Ess2 (1-399 a. a.) lost its ability to associate with snRNAs, whereas the N-terminus domain of Ess2 (1-200 a. a.) associated with Rorγ/γt, but not with snRNAs. Interestingly, experiments using anti-ROR common antibody showed that Rors also associated with U4 and U6 snRNAs. Ess2 knockdown in a T cell hybridoma (68-41 cells) abrogated the interaction between spliceosomes and Rors. An Ess2-dependent association was also found between an lncRNA (Rmrp) and Rors. We thus propose that Ess2 associates with both transcriptional factors and spliceosomal complexes and modulates splicing reactions coupled with transcription factors.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nuclear receptor; Splicing; Transcription; lncRNA

Mesh:

Substances:

Year:  2018        PMID: 29454968     DOI: 10.1016/j.bbrc.2018.02.110

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Biallelic FRA10AC1 variants cause a neurodevelopmental disorder with growth retardation.

Authors:  Leonie von Elsner; Guoliang Chai; Pauline E Schneeberger; Frederike L Harms; Christian Casar; Minyue Qi; Malik Alawi; Ghada M H Abdel-Salam; Maha S Zaki; Florian Arndt; Xiaoxu Yang; Valentina Stanley; Maja Hempel; Joseph G Gleeson; Kerstin Kutsche
Journal:  Brain       Date:  2022-05-24       Impact factor: 15.255

2.  Farnesoid X Receptor Activation Enhances Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.

Authors:  Masahiko Kainuma; Ichiro Takada; Makoto Makishima; Keiji Sano
Journal:  Int J Mol Sci       Date:  2018-06-28       Impact factor: 5.923

Review 3.  In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?

Authors:  Zahra Motahari; Sally Ann Moody; Thomas Michael Maynard; Anthony-Samuel LaMantia
Journal:  J Neurodev Disord       Date:  2019-06-07       Impact factor: 4.025

4.  Case Report: Balanced Reciprocal Translocation t (17; 22) (p11.2; q11.2) and 10q23.31 Microduplication in an Infertile Male Patient Suffering From Teratozoospermia.

Authors:  Shan Huang; Huiling Wu; Yunwei Qi; Liqiang Wei; Xiaodan Lv; Yu He
Journal:  Front Genet       Date:  2022-05-26       Impact factor: 4.772

5.  Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations.

Authors:  Abigael Cheruiyot; Shan Li; Sridhar Nonavinkere Srivatsan; Tanzir Ahmed; Yuhao Chen; Delphine S Lemacon; Ying Li; Zheng Yang; Brian A Wadugu; Wayne A Warner; Shondra M Pruett-Miller; Esther A Obeng; Daniel C Link; Dalin He; Fei Xiao; Xiaowei Wang; Julie M Bailis; Matthew J Walter; Zhongsheng You
Journal:  Cancer Res       Date:  2021-07-02       Impact factor: 12.701

6.  Rare protein-coding variants implicate genes involved in risk of suicide death.

Authors:  Emily DiBlasi; Andrey A Shabalin; Eric T Monson; Brooks R Keeshin; Amanda V Bakian; Anne V Kirby; Elliott Ferris; Danli Chen; Nancy William; Eoin Gaj; Michael Klein; Leslie Jerominski; W Brandon Callor; Erik Christensen; Ken R Smith; Alison Fraser; Zhe Yu; Douglas Gray; Nicola J Camp; Eli A Stahl; Qingqin S Li; Anna R Docherty; Hilary Coon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2021-05-27       Impact factor: 3.358

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.